These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 10396301)
1. HER-2/neu (c-erb-B2) gene and protein in breast cancer. Ross JS; Fletcher JA Am J Clin Pathol; 1999 Jul; 112(1 Suppl 1):S53-67. PubMed ID: 10396301 [TBL] [Abstract][Full Text] [Related]
2. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Ross JS; Fletcher JA Stem Cells; 1998; 16(6):413-28. PubMed ID: 9831867 [TBL] [Abstract][Full Text] [Related]
3. Targeted therapy for cancer: the HER-2/neu and Herceptin story. Ross JS; Gray GS Clin Leadersh Manag Rev; 2003; 17(6):333-40. PubMed ID: 14692077 [TBL] [Abstract][Full Text] [Related]
4. The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy. Ross JS; Fletcher JA Semin Cancer Biol; 1999 Apr; 9(2):125-38. PubMed ID: 10202134 [TBL] [Abstract][Full Text] [Related]
5. Tyrosine kinase activation in breast carcinoma with correlation to HER-2/neu gene amplification and receptor overexpression. Bhargava R; Naeem R; Marconi S; Luszcz J; Garb J; Gasparini R; Otis CN Hum Pathol; 2001 Dec; 32(12):1344-50. PubMed ID: 11774167 [TBL] [Abstract][Full Text] [Related]
6. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689 [TBL] [Abstract][Full Text] [Related]
7. Defining a test for HER-2/neu evaluation in breast cancer in the diagnostic setting. Hanna WM; Kahn HJ; Pienkowska M; Blondal J; Seth A; Marks A Mod Pathol; 2001 Jul; 14(7):677-85. PubMed ID: 11455000 [TBL] [Abstract][Full Text] [Related]
8. Breast cancer in the 21st century: neu opportunities and neu challenges. Schnitt SJ Mod Pathol; 2001 Mar; 14(3):213-8. PubMed ID: 11266529 [TBL] [Abstract][Full Text] [Related]
9. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material. Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540 [TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of HER-2/neu gene amplification in paraffin embedded tumour tissue in women with breast cancer. Zadrozny M; Smolarz B; Romanowicz-Makowska H; Kozłowska E; Kulig A Pol J Pathol; 2002; 53(4):189-93. PubMed ID: 12597335 [TBL] [Abstract][Full Text] [Related]
11. Her-2/neu expression in breast cancer--A comparison of different diagnostic methods. Benöhr P; Henkel V; Speer R; Vogel U; Sotlar K; Aydeniz B; Reiser A; Neubauer H; Tabiti K; Wallwiener D; Clare SE; Kurek R Anticancer Res; 2005; 25(3B):1895-900. PubMed ID: 16158923 [TBL] [Abstract][Full Text] [Related]
12. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas. Smith CA; Pollice AA; Gu LP; Brown KA; Singh SG; Janocko LE; Johnson R; Julian T; Hyams D; Wolmark N; Sweeney L; Silverman JF; Shackney SE Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439 [TBL] [Abstract][Full Text] [Related]
13. Intratumoral heterogeneity of her-2/neu in invasive mammary carcinomas using fluorescence in-situ hybridization and tissue microarray. Shin SJ; Hyjek E; Early E; Knowles DM Int J Surg Pathol; 2006 Oct; 14(4):279-84. PubMed ID: 17041191 [TBL] [Abstract][Full Text] [Related]
14. [Detection of HER-2/neu in breast carcinoma]. Skálová A; Vanĕcek T; Losan F; Papoutsidesová ; Fínek J Cas Lek Cesk; 2003 Feb; 142(2):93-8. PubMed ID: 12698536 [TBL] [Abstract][Full Text] [Related]
15. Algorithm for the diagnosis of HER-2/neu status in breast-infiltrating carcinomas. Falo C; Moreno A; Lloveras B; Figueras A; Varela M; Escobedo A Am J Clin Oncol; 2003 Oct; 26(5):465-70. PubMed ID: 14528071 [TBL] [Abstract][Full Text] [Related]
16. The role of the HER-2/neu oncogene in gynecologic cancers. Cirisano FD; Karlan BY J Soc Gynecol Investig; 1996; 3(3):99-105. PubMed ID: 8796816 [TBL] [Abstract][Full Text] [Related]
17. Correlation of hormone receptors with Her-2 Neu protein expression and the histological grade in invasive breast cancers in a cohort of Saudi Arabia. Arafah M Turk Patoloji Derg; 2012; 28(1):38-43. PubMed ID: 22207430 [TBL] [Abstract][Full Text] [Related]
18. Histopathologic characteristics predicting HER-2/neu amplification in breast cancer. Prati R; Apple SK; He J; Gornbein JA; Chang HR Breast J; 2005; 11(6):433-9. PubMed ID: 16297088 [TBL] [Abstract][Full Text] [Related]
19. Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma. Couturier J; Vincent-Salomon A; Nicolas A; Beuzeboc P; Mouret E; Zafrani B; Sastre-Garau X Mod Pathol; 2000 Nov; 13(11):1238-43. PubMed ID: 11106082 [TBL] [Abstract][Full Text] [Related]
20. Chromogenic in situ hybridization for the detection of HER-2/neu gene amplification in breast cancer with an emphasis on tumors with borderline and low-level amplification: does it measure up to fluorescence in situ hybridization? Bhargava R; Lal P; Chen B Am J Clin Pathol; 2005 Feb; 123(2):237-43. PubMed ID: 15842048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]